Roche Media 20. Feb. 2026 Roche taps Aussie oncologist to lead research—Chutes & Ladders - Fierce Biotech
Cell 19. Feb. 2026 A circadian rheostat drives proton electrochemical gradients to optimize cell-type-specific growth in <em>Arabidopsis</em>
Roche Media 19. Feb. 2026 Roche to end manufacturing of key antibiotic amid EU’s generic woes - Euractiv
Roche Media 18. Feb. 2026 Paragon's latest biotech will try to slow Alzheimer's like Roche - Endpoints News
Illumina 11. Feb. 2026 Ngs Oncology Market Is Going to Boom | Illumina • Roche • Thermo Fisher Scientific - openPR.com
Endpoints News 9. Feb. 2026 #ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%
Roche Media 9. Feb. 2026 Roche’s fenebrutinib demonstrates decade-first benefit in multiple sclerosis - European Pharmaceutical Review
Roche Media 9. Feb. 2026 Roche unveils data behind BTK inhibitor's phase 3 multiple sclerosis win in Ocrevus trial - Fierce Biotech
Roche Media 6. Feb. 2026 Genentech cut at least 489 jobs last year, new filing reveals - Fierce Biotech
Roche Media 2. Feb. 2026 Roche continues RNA return with $1.7B deal for Sanegene drug - Fierce Biotech
Roche Media 29. Jan. 2026 Roche Expands Clinical Research in Mexico, Invests MX$1.2 Billion - Mexico Business News